DEA
DoubleLine ETF Adviser Portfolio holdings
AUM
$263M
1-Year Est. Return
8.83%
This Fund
S&P 500
1 Year Est. Return
+8.83%
AUM
$263M
AUM Growth
-$70.6M
(-21%)
Holding
216
Top Buys
| 1 | +$9.94M | |
| 2 | +$6.91M | |
| 3 | +$4.84M | |
| 4 |
Merck
MRK
|
+$3.57M |
| 5 |
UnitedHealth
UNH
|
+$3.38M |
Top Sells
| 1 | +$9.5M | |
| 2 | +$7.42M | |
| 3 | +$6.53M | |
| 4 |
Coca-Cola
KO
|
+$5.28M |
| 5 |
Philip Morris
PM
|
+$4.88M |
Sector Composition
| 1 | Communication Services | 25.27% |
| 2 | Consumer Discretionary | 25.11% |
| 3 | Healthcare | 24.95% |
| 4 | Real Estate | 24.36% |
| 5 | Technology | 0.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Realty Income
O
$56.7B
| $2.87M | 1.09% |
46,991
-12,010
|
|
||
27
American Tower
AMT
$90.4B
| $2.86M | 1.09% |
16,594
-3,939
|
|
||
28
Walt Disney
DIS
$173B
| $2.78M | 1.06% |
28,828
-5,017
|
|
||
29
Take-Two Interactive
TTWO
$39.8B
| $2.48M | 0.94% |
12,541
-2,200
|
|
||
30
Amgen
AMGN
$189B
| $2.37M | 0.9% |
+6,730
|
|
||
31
Thermo Fisher Scientific
TMO
$176B
| $2.31M | 0.88% |
+4,704
|
|
||
32
Booking.com
BKNG
$129B
| $2.3M | 0.88% |
13,675
-2,425
|
|
||
33
Abbott
ABT
$159B
| $2.25M | 0.86% |
+21,921
|
|
||
34
Lowe's Companies
LOW
$118B
| $2.23M | 0.85% |
9,446
-1,748
|
|
||
35
Public Storage
PSA
$54.4B
| $2.22M | 0.84% |
8,195
-2,030
|
|
||
36
Omnicom Group
OMC
$21.5B
| $2.21M | 0.84% |
29,303
-17,242
|
|
||
37
Live Nation Entertainment
LYV
$37.3B
| $2.2M | 0.84% |
14,457
-8,466
|
|
||
38
Gilead Sciences
GILD
$160B
| $2.17M | 0.83% |
+15,600
|
|
||
39
CBRE Group
CBRE
$38.3B
| $2.12M | 0.8% |
15,614
-3,661
|
|
||
40
Intuitive Surgical
ISRG
$149B
| $2.06M | 0.78% |
+4,467
|
|
||
41
Pfizer
PFE
$148B
| $2.02M | 0.77% |
+72,027
|
|
||
42
Ventas
VTR
$39.9B
| $1.99M | 0.76% |
24,278
-5,138
|
|
||
43
Crown Castle
CCI
$41.2B
| $1.83M | 0.7% |
22,494
-5,602
|
|
||
44
Charter Communications
CHTR
$16.2B
| $1.76M | 0.67% |
8,173
-5,384
|
|
||
45
Starbucks
SBUX
$109B
| $1.73M | 0.66% |
19,348
-3,456
|
|
||
46
Bristol-Myers Squibb
BMY
$117B
| $1.58M | 0.6% |
+26,054
|
|
||
47
Iron Mountain
IRM
$37.1B
| $1.56M | 0.59% |
15,281
-3,794
|
|
||
48
VICI Properties
VICI
$30B
| $1.51M | 0.58% |
55,361
-13,645
|
|
||
49
Danaher
DHR
$130B
| $1.51M | 0.57% |
+7,960
|
|
||
50
Stryker
SYK
$117B
| $1.45M | 0.55% |
+4,409
|
|